{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:29:47Z","timestamp":1793658587399,"version":"4.5.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006445","name":"Uniwersytet Warszawski","doi-asserted-by":"publisher","award":["PSP 501-D125-20-0004316"],"award-info":[{"award-number":["PSP 501-D125-20-0004316"]}],"id":[{"id":"10.13039\/501100006445","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There has been increasing scientific and clinical interest in studying psychedelic and meditation-based interventions in recent years, both in the context of improving mental health and as tools for understanding the mind. Several authors suggest neurophysiological and phenomenological parallels and overlaps between psychedelic and meditative states and suggest synergistic effects of both methods. Both psychedelic-assisted therapy and meditation training in the form of mindfulness-based interventions have been experimentally validated with moderate to large effects as alternative treatments for a variety of mental health problems, including depression, addictions, and anxiety disorders. Both demonstrated significant post-acute and long-term decreases in clinical symptoms and enhancements in well-being in healthy participants, in addition. Postulated shared salutogenic mechanisms, include, among others the ability to alter self-consciousness, present-moment awareness and antidepressant action via corresponding neuromodulatory effects. These shared mechanisms between mindfulness training and psychedelic intervention have led to scientists theorizing, and recently demonstrating, positive synergistic effects when both are used in combination. Research findings suggest that these two approaches can complement each other, enhancing the positive effects of both interventions. However, more theoretical accounts and methodologically sound research are needed before they can be extended into clinical practice. The current review aims to discuss the theoretical rationale of combining psychedelics with mindfulness training, including the predictive coding framework as well as research findings regarding synergies and commonalities between mindfulness training and psychedelic intervention. In addition, suggestions how to combine the two modalities are provided.<\/jats:p>","DOI":"10.1007\/s43440-023-00551-8","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T03:01:22Z","timestamp":1699239682000},"page":"1398-1409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Mindfulness meditation and psychedelics: potential synergies and commonalities"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-3396","authenticated-orcid":false,"given":"Pawe\u0142","family":"Holas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"issue":"11","key":"551_CR1","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Goodwin GM. The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology. 2017;42(11):2105\u201313.","journal-title":"Neuropsychopharmacology"},{"issue":"50","key":"551_CR2","doi-asserted-by":"crossref","first-page":"20254","DOI":"10.1073\/pnas.1112029108","volume":"108","author":"JA Brewer","year":"2011","unstructured":"Brewer JA, Worhunsky PD, Gray JR, Tang YY, Weber J, Kober H. Meditation experience is associated with differences in default mode network activity and connectivity. Proc Natl Acad Sci U S A. 2011;108(50):20254\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"551_CR3","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","volume":"109","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A. 2012;109(6):2138\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"551_CR4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fpsyt.2020.00224","volume":"11","author":"K Heuschkel","year":"2020","unstructured":"Heuschkel K, Kuypers KP. Depression, mindfulness, and psilocybin: possible complementary effects of mindfulness meditation and psilocybin in the treatment of depression. A review Front Psychiatry. 2020;11:224.","journal-title":"A review Front Psychiatry"},{"key":"551_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","volume":"258","author":"S Muttoni","year":"2019","unstructured":"Muttoni S, Ardissino M, John C. Classical psychedelics for the treatment of depression and anxiety: a systematic review. J Affect Disord. 2019;258:11\u201324.","journal-title":"J Affect Disord"},{"issue":"12","key":"551_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181\u201397. https:\/\/doi.org\/10.1177\/0269881116675513. (PMID:27909165;PMCID:PMC5367557).","journal-title":"J Psychopharmacol"},{"key":"551_CR7","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1038\/s41598-019-50612-3","volume":"9","author":"L Smigielski","year":"2019","unstructured":"Smigielski L, Kometer M, Scheidegger M, Kr\u00e4henmann R, Huber T, Vollenweider FX. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Sci Rep. 2019;9:14914.","journal-title":"Sci Rep"},{"issue":"2","key":"551_CR8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1021\/acsptsci.1c00034","volume":"4","author":"JE Payne","year":"2021","unstructured":"Payne JE, Chambers R, Liknaitzky P. Combining psychedelic and mindfulness interventions: synergies to inform clinical practice. ACS Pharmacol Transl Sci. 2021;4(2):416\u201323.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"551_CR9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3389\/fpsyt.2021.707057","volume":"12","author":"ME Eleftheriou","year":"2021","unstructured":"Eleftheriou ME, Thomas E. Examining the potential synergistic effects between mindfulness training and psychedelic-assisted therapy. Front Psychiatry. 2021;12:1330.","journal-title":"Front Psychiatry"},{"issue":"3","key":"551_CR10","first-page":"677","volume":"68","author":"L Grinspoon","year":"2001","unstructured":"Grinspoon L, Doblin R. Psychedelics as catalysts of insight-oriented psychotherapy. Soc Res. 2001;68(3):677\u201395.","journal-title":"Soc Res"},{"issue":"2","key":"551_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/02791072.2006.10399838","volume":"38","author":"M Lerner","year":"2006","unstructured":"Lerner M, Lyvers M. Values and beliefs of psychedelic drug users: a cross-cultural study. J Psychoact Drugs. 2006;38(2):143\u20137.","journal-title":"J Psychoact Drugs"},{"key":"551_CR12","volume-title":"Wherever you go, there you are: mindfulness meditation in everyday life","author":"J Kabat-Zinn","year":"1994","unstructured":"Kabat-Zinn J. Wherever you go, there you are: mindfulness meditation in everyday life. New York: Hyperion; 1994."},{"issue":"6","key":"551_CR13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/1745691611419671","volume":"6","author":"BK H\u00f6lzel","year":"2011","unstructured":"H\u00f6lzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci. 2011;6(6):537\u201359.","journal-title":"Perspect Psychol Sci"},{"key":"551_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cpr.2017.10.011","volume":"59","author":"SB Goldberg","year":"2018","unstructured":"Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin Psychol Rev. 2018;59:52\u201360.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"551_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-018-0115-3","volume":"13","author":"EL Garland","year":"2018","unstructured":"Garland EL, Howard MO. Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research. Addict Sci Clin Pract. 2018;13(1):1\u201314.","journal-title":"Addict Sci Clin Pract"},{"issue":"7","key":"551_CR16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/da.22104","volume":"30","author":"AP King","year":"2013","unstructured":"King AP, Erickson TM, Giardino ND, Favorite T, Rauch SA, Robinson E, et al. A pilot study of group mindfulness-based cognitive therapy (MBCT) for combat veterans with posttraumatic stress disorder (PTSD). Depress Anxiety. 2013;30(7):638\u201345.","journal-title":"Depress Anxiety"},{"key":"551_CR17","volume-title":"The Internet and CBT: a clinical guide","author":"G Andersson","year":"2018","unstructured":"Andersson G. The Internet and CBT: a clinical guide. Boca Raton: CRC Press; 2018."},{"key":"551_CR18","unstructured":"Wardeszkiewicz J, Holas P. Internet-delivered modified Mindfulness-Based Cognitive Therapy (iMBCT) intervention for perceived stress and emotional distress: a pilot RCT study. Psych Res. (under review)."},{"issue":"1","key":"551_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bmb\/ldab005","volume":"138","author":"D Zhang","year":"2021","unstructured":"Zhang D, Lee EKP, Mak ECW, et al. Mindfulness-based interventions: an overall review. Br Med Bull. 2021;138(1):41\u201357.","journal-title":"Br Med Bull"},{"key":"551_CR20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cpr.2016.03.009","volume":"45","author":"MP Spijkerman","year":"2016","unstructured":"Spijkerman MP, Pots WT, Bohlmeijer ET. Effectiveness of online mindfulness-based interventions in improving mental health: a review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016;45:102\u201314.","journal-title":"Clin Psychol Rev"},{"issue":"7","key":"551_CR21","doi-asserted-by":"crossref","DOI":"10.2196\/28168","volume":"8","author":"M Sommers-Spijkerman","year":"2021","unstructured":"Sommers-Spijkerman M, Austin J, Bohlmeijer E, Pots W. New evidence in the booming field of online mindfulness: An updated meta-analysis of randomized controlled trials. JMIR Mental Health. 2021;8(7): e28168.","journal-title":"JMIR Mental Health"},{"issue":"3","key":"551_CR22","doi-asserted-by":"crossref","DOI":"10.2196\/10278","volume":"5","author":"J Sevilla-Llewellyn-Jones","year":"2018","unstructured":"Sevilla-Llewellyn-Jones J, Santesteban-Echarri O, Pryor I, et al. Web-based mindfulness interventions for mental health treatment: systematic review and meta-analysis. JMIR Ment Health. 2018;5(3): e10278.","journal-title":"JMIR Ment Health"},{"key":"551_CR23","volume":"300","author":"X Liu","year":"2021","unstructured":"Liu X, Yi P, Ma L, et al. Mindfulness-based interventions for social anxiety disorder: a systematic review and meta-analysis. Psychiatry Res. 2021;300: 113935.","journal-title":"Psychiatry Res"},{"key":"551_CR24","unstructured":"Holas P, Wardeszkiewicz J, Andersson G. Examining predictors of treatment response and mediators of change in a modified Internet-based MBCT intervention for distressed community sample. (manuscript in preparation)."},{"key":"551_CR25","unstructured":"Holas P, Wardeszkiewicz J. The efficacy and mechanisms of online, 4 weeks Mindfulness-Based Cognitive Therapy (i-MBCT) for Adjustment Disorder and emotional distress related to COVID-19 pandemic. A randomized controlled trial. (manuscript in preparation)."},{"key":"551_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2020.09.134","volume":"279","author":"\u00c9 G\u00e1l","year":"2021","unstructured":"G\u00e1l \u00c9, \u0218tefan S, Cristea IA. The efficacy of mindfulness meditation apps in enhancing users\u2019 well-being and mental health related outcomes: a meta-analysis of randomized controlled trials. J Affect Disord. 2021;279:131\u201342.","journal-title":"J Affect Disord"},{"key":"551_CR27","volume":"9","author":"J Wu","year":"2022","unstructured":"Wu J, Ma Y, Zuo Y, et al. Effects of mindfulness exercise guided by a smartphone app on negative emotions and stress in non-clinical populations: a systematic review and meta-analysis. Front Public Health. 2022;9: 773296.","journal-title":"Front Public Health"},{"issue":"3","key":"551_CR28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187(3):268\u201383 (discussion 284-92).","journal-title":"Psychopharmacology"},{"key":"551_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(83)90464-8","volume":"91","author":"RA Glennon","year":"1983","unstructured":"Glennon RA, Young R, Rosecrans JA. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol. 1983;91:189\u201396.","journal-title":"Eur J Pharmacol"},{"key":"551_CR30","doi-asserted-by":"crossref","first-page":"113612","DOI":"10.1016\/j.biopha.2022.113612","volume":"154","author":"I Erkizia-Santamar\u00eda","year":"2022","unstructured":"Erkizia-Santamar\u00eda I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response. Biomed Pharmacother. 2022;154:113612.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"551_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3):199\u2013214.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"551_CR32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Rev. 2003;55(3):463\u2013508.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"551_CR33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2017;43(1):55\u201360.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"551_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","volume":"177","author":"CM Reiff","year":"2020","unstructured":"Reiff CM. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. 2020;177:391\u2013410.","journal-title":"Am J Psychiatry"},{"key":"551_CR35","volume-title":"Consciousness and the brain: deciphering how the brain codes our thoughts","author":"S Dehaene","year":"2014","unstructured":"Dehaene S. Consciousness and the brain: deciphering how the brain codes our thoughts. Penguin; 2014."},{"key":"551_CR36","doi-asserted-by":"crossref","unstructured":"Letheby C, Gerrans P. Self unbound: ego dissolution in psychedelic experience. Neurosci Conscious. 2017;(1):nix016.","DOI":"10.1093\/nc\/nix016"},{"key":"551_CR37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fnhum.2013.00582","volume":"7","author":"Y Dor-Ziderman","year":"2013","unstructured":"Dor-Ziderman Y, Berkovich-Ohana A, Glicksohn J, Goldstein A. Mindfulness-induced selflessness: a MEG neurophenomenological study. Front Hum Neurosci. 2013;7:582.","journal-title":"Front Hum Neurosci"},{"issue":"10","key":"551_CR38","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1176\/ajp.138.10.1311","volume":"138","author":"L Schenk","year":"1981","unstructured":"Schenk L, Bear D. Multiple personality and related dissociative phenomena in patients with temporal lobe epilepsy. Am J Psychiatry. 1981;138(10):1311\u20136.","journal-title":"Am J Psychiatry"},{"key":"551_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2307\/1384454","volume":"14","author":"RW Hood","year":"1975","unstructured":"Hood RW. The construction and preliminary validation of a measure of reported mystical experience. J Sci Study Reli. 1975;14:29\u201341.","journal-title":"J Sci Study Reli"},{"key":"551_CR40","doi-asserted-by":"crossref","DOI":"10.1515\/9781438433950","volume-title":"Holotropic breathwork: a new approach to self-exploration and therapy","author":"S Grof","year":"2010","unstructured":"Grof S, Grof C. Holotropic breathwork: a new approach to self-exploration and therapy. SUNY Press; 2010."},{"key":"551_CR41","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3389\/fpsyg.2018.01475","volume":"9","author":"R Milli\u00e8re","year":"2018","unstructured":"Milli\u00e8re R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A. Psychedelics, meditation, and self-consciousness. Front Psychol. 2018;9:1475.","journal-title":"Front Psychol"},{"key":"551_CR42","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","volume":"45","author":"NL Mason","year":"2020","unstructured":"Mason NL, Kuypers KPC, M\u00fcller F, Reckweg J, Tse DHY, Toennes SW, et al. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology. 2020;45:2003\u201311.","journal-title":"Neuropsychopharmacology"},{"key":"551_CR43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","volume":"4","author":"DB Yaden","year":"2020","unstructured":"Yaden DB, Griffiths RR. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol Transl Sci. 2020;4:568\u201372.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"551_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","volume":"1124","author":"RL Buckner","year":"2008","unstructured":"Buckner RL, Andrews-Hanna JR, Schacter DL. The brain\u2019s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1\u201338.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"551_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.12360","volume":"1316","author":"JR Andrews-Hanna","year":"2014","unstructured":"Andrews-Hanna JR, Smallwood J, Spreng RN. The default network and self-generated thought: component processes, dynamic control, and clinical relevance. Ann N Y Acad Sci. 2014;1316(1):29\u201352.","journal-title":"Ann N Y Acad Sci"},{"key":"551_CR46","first-page":"20","volume":"8","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, et al. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci. 2014;8:20.","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"551_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","volume":"10","author":"F Palhano-Fontes","year":"2015","unstructured":"Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, et al. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS ONE. 2015;10(2): e0118143.","journal-title":"PLoS ONE"},{"issue":"18","key":"551_CR48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","volume":"7","author":"F M\u00fcller","year":"2018","unstructured":"M\u00fcller F, Dolder PC, Schmidt A, Liechti ME, Borgwardt S. Altered network hub connectivity after acute LSD administration. Neuroimage Clin. 2018;7(18):694\u2013701.","journal-title":"Neuroimage Clin"},{"issue":"3","key":"551_CR49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.bp.116.194738","volume":"210","author":"MM Nour","year":"2017","unstructured":"Nour MM, Carhart-Harris RL. Psychedelics and the science of self-experience. Br J Psychiatry. 2017;210(3):177\u20139.","journal-title":"Br J Psychiatry"},{"key":"551_CR50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","volume":"142","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL. The entropic brain-revisited. Neuropharmacology. 2018;142:167\u201378.","journal-title":"Neuropharmacology"},{"issue":"15","key":"551_CR51","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1523\/JNEUROSCI.4135-11.2012","volume":"32","author":"G Pagnoni","year":"2012","unstructured":"Pagnoni G. Dynamical properties of BOLD activity from the ventral posteromedial cortex associated with meditation and attentional skills. J Neurosci. 2012;32(15):5242\u20139.","journal-title":"J Neurosci"},{"issue":"10","key":"551_CR52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/rel13100983","volume":"13","author":"P Marshall","year":"2022","unstructured":"Marshall P. Does mystical experience give access to reality? Religions. 2022;13(10):983.","journal-title":"Religions"},{"key":"551_CR53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/7854_2017_474","volume":"36","author":"FS Barrett","year":"2018","unstructured":"Barrett FS, Griffiths RR. Classic hallucinogens and mystical experiences: phenomenology and neural correlates. Curr Top Behav Neurosci. 2018;36:393\u2013430.","journal-title":"Curr Top Behav Neurosci"},{"issue":"11","key":"551_CR54","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","volume":"25","author":"E Studerus","year":"2011","unstructured":"Studerus E, Kometer M, Hasler F, Vollenweider FX. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol. 2011;25(11):1434\u201352.","journal-title":"J Psychopharmacol"},{"key":"551_CR55","doi-asserted-by":"crossref","unstructured":"Arce JMR, Winkelman MJ. Psychedelics, sociality, and human evolution. Front Psychol. 2021;12.","DOI":"10.3389\/fpsyg.2021.729425"},{"issue":"5","key":"551_CR56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00213-015-4162-0","volume":"233","author":"J Soler","year":"2016","unstructured":"Soler J, Elices M, Franquesa A, Barker S, Friedlander P, Feilding A, et al. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities. Psychopharmacology. 2016;233(5):823\u20139.","journal-title":"Psychopharmacology"},{"key":"551_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","volume":"33","author":"MK Madsen","year":"2020","unstructured":"Madsen MK, Fisher PM, Stenb\u00e6k DS, Kristiansen S, Burmester D, Lehel S, et al. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. Eur Neuropsychopharmacol. 2020;33:71\u201380.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"551_CR58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 2018;235(2):399\u2013408.","journal-title":"Psychopharmacology"},{"issue":"1","key":"551_CR59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s12671-020-01308-7","volume":"11","author":"CA Hunt","year":"2020","unstructured":"Hunt CA, Hoffman MA, Mohr JJ, Williams AL. Assessing perceived barriers to meditation: the determinants of meditation practice inventory-revised (DMPI-R). Mindfulness. 2020;11(1):1139\u201349.","journal-title":"Mindfulness"},{"issue":"10","key":"551_CR60","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s12671-022-01977-6","volume":"13","author":"NI Bowles","year":"2022","unstructured":"Bowles NI, Davies JN, Van Dam NT. Dose\u2013response relationship of reported lifetime meditation practice with mental health and wellbeing: a cross-sectional study. Mindfulness. 2022;13(10):2529\u201346.","journal-title":"Mindfulness"},{"issue":"2","key":"551_CR61","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):264\u2013355.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"551_CR62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X","volume":"38","author":"H Hall","year":"2000","unstructured":"Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. Synapse. 2000;38(4):421\u201331.","journal-title":"Synapse"},{"issue":"6","key":"551_CR63","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00726-011-1078-9","volume":"42","author":"A Saulin","year":"2012","unstructured":"Saulin A, Savli M, Lanzenberger R. Serotonin and molecular neuroimaging in humans using PET. Amino Acids. 2012;42(6):2039\u201357.","journal-title":"Amino Acids"},{"issue":"1\u20132","key":"551_CR64","first-page":"121","volume":"73","author":"RJ Strassman","year":"1996","unstructured":"Strassman RJ. Human psychopharmacology of N, N-dimethyltryptamine. Behav Brain Res. 1996;73(1\u20132):121\u20134.","journal-title":"Behav Brain Res"},{"issue":"7","key":"551_CR65","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/ph14070659","volume":"14","author":"A Kozlowska","year":"2021","unstructured":"Kozlowska A, Wojtyna E, Rychert J. The role of the 5-HT2B RECEPTOR IN NEUROPSYCHIATRIC DISORDERS. Pharmaceuticals. 2021;14(7):659.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"551_CR66","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","volume":"20","author":"FX Vollenweider","year":"1999","unstructured":"Vollenweider FX, Vontobel P, Hell D, Leenders KL. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2013a PET study with [11C]raclopride. Neuropsychopharmacology. 1999;20(5):424\u201333. https:\/\/doi.org\/10.1016\/S0893-133X(98)00108-0. (PMID: 10192823).","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"551_CR67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","volume":"21","author":"FX Vollenweider","year":"2020","unstructured":"Vollenweider FX, Preller KH. Psychedelic drugs: Neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosci. 2020;21(11):611\u201324.","journal-title":"Nat Rev Neurosci"},{"key":"551_CR68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrn2555","volume":"10","author":"AD Craig","year":"2009","unstructured":"Craig AD. How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10:59\u201310.","journal-title":"Nat Rev Neurosci"},{"key":"551_CR69","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.tics.2013.09.007","volume":"17","author":"AK Seh","year":"2013","unstructured":"Seh AK. Interoceptive inference, emotion, and the embodied self. Trend Cogn Sci. 2013;17:565\u201373.","journal-title":"Trend Cogn Sci"},{"issue":"3","key":"551_CR70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","volume":"26","author":"JJ Gattuso","year":"2023","unstructured":"Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, et al. Default mode network modulation by psychedelics: a systematic review. Int J Neuropsychopharmacol. 2023;26(3):155\u201388.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"17","key":"551_CR71","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 2016;113(17):4853\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"551_CR72","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1073\/pnas.1611898114","volume":"114","author":"S Atasoy","year":"2017","unstructured":"Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci. 2017;114(17):4348\u2013435.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"551_CR73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrn3916","volume":"16","author":"YY Tang","year":"2015","unstructured":"Tang YY, H\u00f6lzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16(4):213\u201325.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"551_CR74","first-page":"423","volume":"36","author":"MR Tolahunase","year":"2018","unstructured":"Tolahunase MR, Sagar R, Faiq M, Dada R. Yoga-and meditation-based lifestyle intervention increases neuroplasticity and reduces the severity of major depressive disorder: a randomized controlled trial. Restor Neurol Neurosci. 2018;36(3):423\u201342.","journal-title":"Restor Neurol Neurosci"},{"issue":"9","key":"551_CR75","first-page":"3207","volume":"36","author":"AV Lebedev","year":"2015","unstructured":"Lebedev AV, Kaelen M, L\u00f6vd\u00e9n M, Nilsson J, Feilding A, Nutt DJ, et al. LSD-induced entropic brain activity predicts subsequent personality change. Hum Brain Mapp. 2015;36(9):3207\u201317.","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"551_CR76","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1177\/0956797613485603","volume":"24","author":"P Condon","year":"2013","unstructured":"Condon P, Desbordes G, Miller WB, DeSteno D. Meditation increases compassionate responses to suffering. Psychol Sci. 2013;24(10):2125\u20137.","journal-title":"Psychol Sci"},{"issue":"5","key":"551_CR77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","volume":"57","author":"R Watts","year":"2017","unstructured":"Watts R, Day C, Krzanowski J, Nutt D, Carhart-Harris R. Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression. J Humanist Psychol. 2017;57(5):520\u201364.","journal-title":"J Humanist Psychol"},{"key":"551_CR78","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3389\/fpsyt.2019.00881","volume":"10","author":"K Preller","year":"2019","unstructured":"Preller K, Vollenweider F. Modulation of social cognition via hallucinogens and \u201cEntactogens.\u201d Front Psychiatry. 2019;10:881.","journal-title":"Front Psychiatry"},{"issue":"9","key":"551_CR79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","volume":"20","author":"T Pokorny","year":"2017","unstructured":"Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. Effect of psilocybin on empathy and moral decision-making. Int J Neuropsychopharmacol. 2017;20(9):747\u201357.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"551_CR80","doi-asserted-by":"crossref","first-page":"205510292097812","DOI":"10.1177\/2055102920978123","volume":"7","author":"S Gandy","year":"2020","unstructured":"Gandy S, Forstmann M, Carhart-Harris RL, Timmermann C, Luke D, Watts R, et al. The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychol Open. 2020;7(2):2055102920978123.","journal-title":"Health Psychol Open"},{"issue":"6","key":"551_CR81","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1017\/S0033291716003317","volume":"47","author":"R Crane","year":"2017","unstructured":"Crane R, Brewer J, Feldman C, Kabat-Zinn J, Santorelli S, Williams J, et al. What defines mindfulness-based programs? The warp and the weft. Psychol Med. 2017;47(6):990\u20139.","journal-title":"Psychol Med"},{"key":"551_CR82","doi-asserted-by":"crossref","unstructured":"Timmermann C, Bauer PR, Gosseries O, Vanhaudenhuyse A, Vollenweider F, Laureys S, et al. A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics. Trends Cogn Sci. 2023.","DOI":"10.1016\/j.tics.2022.11.006"},{"issue":"1","key":"551_CR83","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1038\/s41598-023-36184-3","volume":"13","author":"B Weiss","year":"2023","unstructured":"Weiss B, Wingert A, Erritzoe D, Campbell WK. Prevalence and therapeutic impact of adverse life events re-experiencing under ceremonial ayahuasca. Sci Rep. 2023;13(1):9438.","journal-title":"Sci Rep"},{"issue":"2","key":"551_CR84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/070674371205700203","volume":"57","author":"NA Farb","year":"2012","unstructured":"Farb NA, Anderson AK, Segal ZV. The mindful brain and emotion regulation in mood disorders. Can J Psychiatry. 2012;57(2):70\u20137.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"551_CR85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/0963721413495869","volume":"22","author":"R Teper","year":"2013","unstructured":"Teper R, Segal ZV, Inzlicht M. Inside the mindful mind: how mindfulness enhances emotion regulation through improvements in executive control. Curr Dir Psychol Sci. 2013;22(6):449\u201354.","journal-title":"Curr Dir Psychol Sci"},{"issue":"6","key":"551_CR86","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/PSY.0000000000000955","volume":"83","author":"T Barnhofer","year":"2021","unstructured":"Barnhofer T, Reess TJ, Fissler M, Winnebeck E, Grimm S, G\u00e4rtner M, et al. Effects of mindfulness training on emotion regulation in patients with depression: reduced dorsolateral prefrontal cortex activation indexes early beneficial changes. Psychosom Med. 2021;83(6):579\u201391.","journal-title":"Psychosom Med"},{"issue":"8","key":"551_CR87","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/02698811221089034","volume":"36","author":"P Or\u0142owski","year":"2022","unstructured":"Or\u0142owski P, Ruban A, Szczypi\u0144ski J, Hobot J, Bielecki M, Bola M. Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: the mediating role of ego-dissolution and mystical experiences. J Psychopharmacol. 2022;36(8):987\u20131000.","journal-title":"J Psychopharmacol"},{"key":"551_CR88","doi-asserted-by":"crossref","unstructured":"Lafrance A, Strahan E, Bird BM, St. Pierre M, Walsh Z. Classic psychedelic use and mechanisms of mental health: exploring the mediating roles of spirituality and emotion processing on symptoms of anxiety, depressed mood, and disordered eating in a community sample. J Humanist Psychol. 2021.","DOI":"10.1177\/00221678211048049"},{"key":"551_CR89","doi-asserted-by":"crossref","first-page":"1151626","DOI":"10.3389\/fpsyg.2023.1151626","volume":"14","author":"O Simonsson","year":"2023","unstructured":"Simonsson O, Stenfors CUD, Goldberg SB, Hendricks PS, Osika W. Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development. Front Psychol. 2023;14:1151626.","journal-title":"Front Psychol"},{"key":"551_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cpr.2015.01.006","volume":"37","author":"J Gu","year":"2015","unstructured":"Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and well-being? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1\u201312.","journal-title":"Clin Psychol Rev"},{"key":"551_CR91","first-page":"1892","volume":"6","author":"E Visted","year":"2015","unstructured":"Visted E, V\u00f8llestad J, Nielsen MB, Schanche E. Emotion regulation in current and remitted depression: a systematic review and meta-analysis. Front Psychol. 2015;6:1892.","journal-title":"Front Psychol"},{"issue":"3","key":"551_CR92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/02698811211073758","volume":"36","author":"M Wolff","year":"2022","unstructured":"Wolff M, Mertens LJ, Walter M, Enge S, Evens R. The Acceptance\/Avoidance-Promoting Experiences Questionnaire (APEQ): a theory-based approach to psychedelic drugs\u2019 effects on psychological flexibility. J Psychopharmacol. 2022;36(3):387\u2013408.","journal-title":"J Psychopharmacol"},{"key":"551_CR93","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fpsyt.2021.661233","volume":"12","author":"R Ko\u010d\u00e1rov\u00e1","year":"2021","unstructured":"Ko\u010d\u00e1rov\u00e1 R, Hor\u00e1\u010dek J, Carhart-Harris R. Does psychedelic therapy have a transdiagnostic action and prophylactic potential? Front Psychiatry. 2021;12:1068.","journal-title":"Front Psychiatry."},{"issue":"7","key":"551_CR94","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016;3(7):619\u201327.","journal-title":"Lancet Psychiatry"},{"issue":"04","key":"551_CR95","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/a-1341-1907","volume":"54","author":"LJ Mertens","year":"2021","unstructured":"Mertens LJ, Preller KH. Classical psychedelics as therapeutics in psychiatry\u2013current clinical evidence and potential therapeutic mechanisms in substance use and mood disorders. Pharmacopsychiatry. 2021;54(04):176\u201390.","journal-title":"Pharmacopsychiatry"},{"key":"551_CR96","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.724606","volume":"12","author":"CM De Vos","year":"2021","unstructured":"De Vos CM, Mason NL, Kuypers KP. Psychedelics and neuroplasticity: a systematic review unravelling the biological underpinnings of psychedelics. Front Psychiatry. 2021;12: 724606.","journal-title":"Front Psychiatry"},{"key":"551_CR97","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104793","volume":"140","author":"M van Elk","year":"2022","unstructured":"van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review. Neurosci Biobehav Rev. 2022;140: 104793.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"551_CR98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0898010111435949","volume":"30","author":"CA Lengacher","year":"2012","unstructured":"Lengacher CA, Kip KE, Barta M, Post-White J, Jacobsen PB, Groer M, et al. A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. J Holist Nurs. 2012;30(3):170\u201385.","journal-title":"J Holist Nurs"},{"issue":"10","key":"551_CR99","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1037\/ccp0000122","volume":"84","author":"E Walsh","year":"2016","unstructured":"Walsh E, Eisenlohr-Moul T, Baer R. Brief mindfulness training reduces salivary IL-6 and TNF-\u03b1 in young women with depressive symptomatology. J Consult Clin Psychol. 2016;84(10):887.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"551_CR100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.1997.tb52132.x","volume":"816","author":"A Chryssikopoulos","year":"1997","unstructured":"Chryssikopoulos A. The relationship between the immune and endocrine systems. Ann New Y Acad Sci. 1997;816(1):83\u201393.","journal-title":"Ann New Y Acad Sci"},{"issue":"2","key":"551_CR101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study. Psychopharmacology. 2004;172(2):145\u201356.","journal-title":"Psychopharmacology"},{"issue":"3","key":"551_CR102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0306-4530(01)00061-0","volume":"27","author":"SJ Lupien","year":"2002","unstructured":"Lupien SJ, Wilkinson CW, Bri\u00e8re S, M\u00e9nard C, Ng Ying Kin NMK, Nair NPV. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology. 2002;27(3):401\u201316.","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"551_CR103","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cercor\/bhn204","volume":"19","author":"P V\u00e1zquez-Borsetti","year":"2009","unstructured":"V\u00e1zquez-Borsetti P, Cort\u00e9s R, Artigas F. Pyramidal neurons in rat prefrontal cortex projecting to the ventral tegmental area and dorsal raphe nucleus express 5-HT2A-receptors. Cereb Cortex. 2009;19(7):1678\u201386.","journal-title":"Cereb Cortex"},{"issue":"1","key":"551_CR104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstad AL, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011;68(1):71\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"551_CR105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/brbi.1999.0579","volume":"14","author":"J Stefulj","year":"2000","unstructured":"Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun. 2000;14(3):219\u201324.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"551_CR106","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.tips.2017.08.003","volume":"38","author":"EJ Kyzar","year":"2017","unstructured":"Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. Psychedelic drugs in biomedicine. Trends Pharmacol Sci. 2017;38(11):992\u20131005.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"551_CR107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08923979409029898","volume":"16","author":"RV House","year":"1994","unstructured":"House RV, Thomas PT, Bhargava HN. Immunological consequences of in vitro exposure to lysergic acid diethylamide (LSD). Immunopharmacol Immunotoxicol. 1994;16(1):23\u201340.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"551_CR108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","volume":"196","author":"L Smigielski","year":"2019","unstructured":"Smigielski L, Scheidegger M, Kometer M, Vollenweider FX. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Neuroimage. 2019;196:207\u201315.","journal-title":"Neuroimage"},{"issue":"2","key":"551_CR109","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrn2787","volume":"11","author":"K Friston","year":"2010","unstructured":"Friston K. The free-energy principle: a unified brain theory? Nat Rev Neurosci. 2010;11(2):127\u201338.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"551_CR110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2215-0366(14)70275-5","volume":"1","author":"KJ Friston","year":"2014","unstructured":"Friston KJ, Stephan KE, Montague R, Dolan RJ. Computational psychiatry: the brain as a phantastic organ. Lancet Psychiatry. 2014;1(2):148\u201358.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"551_CR111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003094","volume":"9","author":"M Joffily","year":"2013","unstructured":"Joffily M, Coricelli G. Emotional valence and the free-energy principle. PLoS Comput Biol. 2013;9(6): e1003094.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"551_CR112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/17540739211063851","volume":"14","author":"M Miller","year":"2022","unstructured":"Miller M, Kiverstein J, Rietveld E. The predictive dynamics of happiness and well-being. Emot Rev. 2022;14(1):15\u201330.","journal-title":"Emot Rev"},{"key":"551_CR113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neubiorev.2021.06.021","volume":"128","author":"RE Laukkonen","year":"2021","unstructured":"Laukkonen RE, Slagter HA. From many to (n)one: meditation and the plasticity of the predictive mind. Neurosci Biobehav Rev. 2021;128:199\u2013217.","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"551_CR114","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1162\/neco_a_00999","volume":"29","author":"KJ Friston","year":"2017","unstructured":"Friston KJ, Lin M, Frith CD, Pezzulo G, Hobson JA, Ondobaka S. Active inference, curiosity and insight. Neural Comput. 2017;29(10):2633\u201383.","journal-title":"Neural Comput"},{"issue":"3","key":"551_CR115","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ. REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev. 2019;71(3):316\u201344.","journal-title":"Pharmacol Rev"},{"key":"551_CR116","doi-asserted-by":"crossref","unstructured":"Magni G, Tuena C, Riva G. A predictive coding approach to psychedelic virtual-induced hallucinations and creative cognition in ageing. Front Hum Neurosci. 2023.","DOI":"10.3389\/fnhum.2023.1219052"},{"key":"551_CR117","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s12671-017-0849-0","volume":"9","author":"SK Kamboj","year":"2018","unstructured":"Kamboj SK, Walld\u00e9n YSE, Falconer CJ, Alotaibi MR, Blagbrough IS, Husbands SM, Freeman TP. Additive effects of 3,4-methylenedioxymethamphetamine (MDMA) and compassionate imagery on self-compassion in recreational users of ecstasy. Mindfulness. 2018;9:1134\u201345.","journal-title":"Mindfulness"},{"issue":"6","key":"551_CR118","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.beth.2017.06.003","volume":"48","author":"JN Kirby","year":"2017","unstructured":"Kirby JN, Tellegen CL, Steindl SR. A meta-analysis of compassion-based interventions: current state of knowledge and future directions. Behav Ther. 2017;48(6):778\u201392.","journal-title":"Behav Ther"},{"issue":"10","key":"551_CR119","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s00213-022-06221-6","volume":"239","author":"M Butler","year":"2022","unstructured":"Butler M, Jelen L, Rucker J. Expectancy in placebo-controlled trials of psychedelics: if so, so what? Psychopharmacology. 2022;239(10):3047\u201355.","journal-title":"Psychopharmacology"},{"key":"551_CR120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1037\/a0039512","volume":"70","author":"RJ Davidson","year":"2015","unstructured":"Davidson RJ, Kaszniak AW. Conceptual and methodological issues in research on mindfulness and meditation. Am Psychol. 2015;70:581\u201392.","journal-title":"Am Psychol"},{"issue":"10","key":"551_CR121","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s00213-022-06221-6","volume":"239","author":"M Butler","year":"2022","unstructured":"Butler M, Jelen L, Rucker J. Expectancy in placebo-controlled trials of psychedelics: if so, so what? Psychopharmacology. 2022;239(10):3047\u201355.","journal-title":"Psychopharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-023-00551-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:09:24Z","timestamp":1730462964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-023-00551-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":121,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1007\/s43440-023-00551-8","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PH and JK declare no conflict of interest in the presented area.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}